Praxis Precision Medicines (PRAX) Gains from Investment Securities (2019 - 2026)
Praxis Precision Medicines (PRAX) recorded quarterly Gains from Investment Securities of $12.9 million in Q1 2026, up 1123.2% quarter-over-quarter from -$1.3 million in Q4 2025.
Praxis Precision Medicines (PRAX) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $12.9 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities changed N/A year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (up 7461.4% YoY), while the FY2025 annual figure was $7000.0, down 97.73% from the prior year.
- Gains from Investment Securities was $12.9 million for Q1 2026 at Praxis Precision Medicines, up from -$1.3 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $12.9 million in Q1 2026 to a low of -$1.3 million in Q4 2025.
- Historically, Gains from Investment Securities has averaged $852187.5 across 5 years, with a median of $14500.0 in 2022.
- Biggest YoY gain for Gains from Investment Securities was 9269.23% in 2025; the steepest drop was 904.46% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $7000.0 in 2022, then decreased by 28.57% to $5000.0 in 2023, then soared by 3040.0% to $157000.0 in 2024, then plunged by 904.46% to -$1.3 million in 2025, then jumped by 1123.2% to $12.9 million in 2026.
- The last three Gains from Investment Securities figures came in at $12.9 million (Q1 2026), -$1.3 million (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Praxis Precision Medicines | 200.22 Mn | -586.65 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.92 Mn |
| Mar 31, 2026 | 12.92 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Dec 31, 2024 | 157,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |